I’m convinced that the signing of the licensing deal is either tied directly to the FDA deciding on the dose or submission of the BLA. When either of those happen, or both, the licensing deal will be signed.

Honestly, how long does it take the FDA to review some simple data on a drug with zero recorded side effects? Tamiflu was approved after a trial of approximately 800 patients and it had all kinds of side effects. So many side effects, including severe ones, that some doctors and journals believe the benefits of Tamiflu do not outweigh the side effects

The news regarding the CTC going to zero is exciting. I agree that if CYDY were on the NYSE and had funding, these news would be ground breaking and contribute nicely to the market value/SP. Unfortunately CYDY is deficient in both of those categories which leads to a no-reaction to the news. I believe having multiple patients with similar results will help, but ultimately without being on a legit exchange and having funding, it won’t do much without FDA approving BTD. We’ll see, but I’m excited and hope that leronlimab will show results in other cancers as well.

Let’s get that basket trial going!